The Australian Genetics of Depression Study, which is the Australian arm of an international study created to understand the genetics of depression, is recruiting Australian adults - aged 18 and above - who have been treated for clinical depression.

Clinical depression is a common mental illness, often referred to as depression, which will affect almost one in five people during their lifetime.

The World Health Organization (WHO) predicts that by 2020, clinical depression will impose the second highest burden of any disease in Australia and other advanced countries.

The overarching objective of the Australian Genetics of Depression Study is to learn more about the genetic drivers of clinical depression, and the genetic factors that influence the effectiveness of various clinical depression treatments.

Study researchers are working to recruit more than 20,000 Australians aged 18+ to the study who: